Home NDC 68727-900 Rylaze
Product NDC 68727-900
11-digit product format 687270900
Labeler code 68727
Product ID 68727-900_cca29ff5-d000-43da-b64a-c65816a8a9c4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name asparaginase erwinia chrysanthemi (recombinant)-rywn
Dosage form INJECTION
Route INTRAMUSCULAR
Labeler Jazz Pharmaceuticals, Inc.
Application BLA761179
Marketing category BLA
Marketing start 2021-06-30
Substance ASPARAGINASE
Active strength 20 mg/mL
Pharmacologic classes Asparaginase [CS], Asparagine-specific Enzyme [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Rylaze
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ASPARAGINASE 20 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination G4FQ3CKY5R Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2561251 Internal RxNorm lookup 2561256 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68727-900-01 Rylaze 0.5 mL in 1 VIAL, SINGLE-DOSE INJECTION 0.5 7 68727-900-03 Rylaze 3 in 1 CARTON INJECTION 3 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68727-900 RYLAZE (ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN) INJECTION [JAZZ PHARMACEUTICALS, INC.] 6 Current NDC, Legacy NDC, 2 package rows 20241010_857e53aa-1098-4dad-b654-0276cdd43e03.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Rylaze ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN Jazz Pharmaceuticals, Inc. 857e53aa-1098-4dad-b654-0276cdd43e03 2025-07-01 Warnings, Adverse reactions Exact identifier application number: BLA761179 ndc (product): 68727-900
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761179 Rylaze asparaginase erwinia chrysanthemi (recombinant)-rywn 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68727-900-01 68727090001 0.5 mL in 1 VIAL, SINGLE-DOSE 0.5 ml Historical 68727-900-03 68727090003 3 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03) / .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01) 2021-06-30 0000-00-00 No No Current